Medicine for Osteoarthritis Pain Market - Global Outlook and Forecast 2021-2027

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Medicine for Osteoarthritis Pain Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Medicine for Osteoarthritis Pain Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Medicine for Osteoarthritis Pain Overall Market Size
2.1 Global Medicine for Osteoarthritis Pain Market Size: 2021 VS 2027
2.2 Global Medicine for Osteoarthritis Pain Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Medicine for Osteoarthritis Pain Sales (Consumption): 2016-2027
3 Company Landscape
3.1 Top Medicine for Osteoarthritis Pain Players in Global Market
3.2 Top Global Medicine for Osteoarthritis Pain Companies Ranked by Revenue
3.3 Global Medicine for Osteoarthritis Pain Revenue by Companies
3.4 Global Medicine for Osteoarthritis Pain Sales by Companies
3.5 Global Medicine for Osteoarthritis Pain Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Medicine for Osteoarthritis Pain Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Medicine for Osteoarthritis Pain Product Type
3.8 Tier 1, Tier 2 and Tier 3 Medicine for Osteoarthritis Pain Players in Global Market
3.8.1 List of Global Tier 1 Medicine for Osteoarthritis Pain Companies
3.8.2 List of Global Tier 2 and Tier 3 Medicine for Osteoarthritis Pain Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Medicine for Osteoarthritis Pain Market Size Markets, 2021 & 2027
4.1.2 Oral
4.1.3 Injection
4.1.4 External
4.2 By Type - Global Medicine for Osteoarthritis Pain Revenue & Forecasts
4.2.1 By Type - Global Medicine for Osteoarthritis Pain Revenue, 2016-2021
4.2.2 By Type - Global Medicine for Osteoarthritis Pain Revenue, 2022-2027
4.2.3 By Type - Global Medicine for Osteoarthritis Pain Revenue Market Share, 2016-2027
4.3 By Type - Global Medicine for Osteoarthritis Pain Sales & Forecasts
4.3.1 By Type - Global Medicine for Osteoarthritis Pain Sales, 2016-2021
4.3.2 By Type - Global Medicine for Osteoarthritis Pain Sales, 2022-2027
4.3.3 By Type - Global Medicine for Osteoarthritis Pain Sales Market Share, 2016-2027
4.4 By Type - Global Medicine for Osteoarthritis Pain Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Medicine for Osteoarthritis Pain Market Size, 2021 & 2027
5.1.2 Medical Care
5.1.3 Personal Care
5.2 By Application - Global Medicine for Osteoarthritis Pain Revenue & Forecasts
5.2.1 By Application - Global Medicine for Osteoarthritis Pain Revenue, 2016-2021
5.2.2 By Application - Global Medicine for Osteoarthritis Pain Revenue, 2022-2027
5.2.3 By Application - Global Medicine for Osteoarthritis Pain Revenue Market Share, 2016-2027
5.3 By Application - Global Medicine for Osteoarthritis Pain Sales & Forecasts
5.3.1 By Application - Global Medicine for Osteoarthritis Pain Sales, 2016-2021
5.3.2 By Application - Global Medicine for Osteoarthritis Pain Sales, 2022-2027
5.3.3 By Application - Global Medicine for Osteoarthritis Pain Sales Market Share, 2016-2027
5.4 By Application - Global Medicine for Osteoarthritis Pain Price (Manufacturers Selling Prices), 2016-2027
6 Sights by Region
6.1 By Region - Global Medicine for Osteoarthritis Pain Market Size, 2021 & 2027
6.2 By Region - Global Medicine for Osteoarthritis Pain Revenue & Forecasts
6.2.1 By Region - Global Medicine for Osteoarthritis Pain Revenue, 2016-2021
6.2.2 By Region - Global Medicine for Osteoarthritis Pain Revenue, 2022-2027
6.2.3 By Region - Global Medicine for Osteoarthritis Pain Revenue Market Share, 2016-2027
6.3 By Region - Global Medicine for Osteoarthritis Pain Sales & Forecasts
6.3.1 By Region - Global Medicine for Osteoarthritis Pain Sales, 2016-2021
6.3.2 By Region - Global Medicine for Osteoarthritis Pain Sales, 2022-2027
6.3.3 By Region - Global Medicine for Osteoarthritis Pain Sales Market Share, 2016-2027
6.4 North America
6.4.1 By Country - North America Medicine for Osteoarthritis Pain Revenue, 2016-2027
6.4.2 By Country - North America Medicine for Osteoarthritis Pain Sales, 2016-2027
6.4.3 US Medicine for Osteoarthritis Pain Market Size, 2016-2027
6.4.4 Canada Medicine for Osteoarthritis Pain Market Size, 2016-2027
6.4.5 Mexico Medicine for Osteoarthritis Pain Market Size, 2016-2027
6.5 Europe
6.5.1 By Country - Europe Medicine for Osteoarthritis Pain Revenue, 2016-2027
6.5.2 By Country - Europe Medicine for Osteoarthritis Pain Sales, 2016-2027
6.5.3 Germany Medicine for Osteoarthritis Pain Market Size, 2016-2027
6.5.4 France Medicine for Osteoarthritis Pain Market Size, 2016-2027
6.5.5 U.K. Medicine for Osteoarthritis Pain Market Size, 2016-2027
6.5.6 Italy Medicine for Osteoarthritis Pain Market Size, 2016-2027
6.5.7 Russia Medicine for Osteoarthritis Pain Market Size, 2016-2027
6.5.8 Nordic Countries Medicine for Osteoarthritis Pain Market Size, 2016-2027
6.5.9 Benelux Medicine for Osteoarthritis Pain Market Size, 2016-2027
6.6 Asia
6.6.1 By Region - Asia Medicine for Osteoarthritis Pain Revenue, 2016-2027
6.6.2 By Region - Asia Medicine for Osteoarthritis Pain Sales, 2016-2027
6.6.3 China Medicine for Osteoarthritis Pain Market Size, 2016-2027
6.6.4 Japan Medicine for Osteoarthritis Pain Market Size, 2016-2027
6.6.5 South Korea Medicine for Osteoarthritis Pain Market Size, 2016-2027
6.6.6 Southeast Asia Medicine for Osteoarthritis Pain Market Size, 2016-2027
6.6.7 India Medicine for Osteoarthritis Pain Market Size, 2016-2027
6.7 South America
6.7.1 By Country - South America Medicine for Osteoarthritis Pain Revenue, 2016-2027
6.7.2 By Country - South America Medicine for Osteoarthritis Pain Sales, 2016-2027
6.7.3 Brazil Medicine for Osteoarthritis Pain Market Size, 2016-2027
6.7.4 Argentina Medicine for Osteoarthritis Pain Market Size, 2016-2027
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Medicine for Osteoarthritis Pain Revenue, 2016-2027
6.8.2 By Country - Middle East & Africa Medicine for Osteoarthritis Pain Sales, 2016-2027
6.8.3 Turkey Medicine for Osteoarthritis Pain Market Size, 2016-2027
6.8.4 Israel Medicine for Osteoarthritis Pain Market Size, 2016-2027
6.8.5 Saudi Arabia Medicine for Osteoarthritis Pain Market Size, 2016-2027
6.8.6 UAE Medicine for Osteoarthritis Pain Market Size, 2016-2027
7 Manufacturers & Brands Profiles
7.1 Pfizer
7.1.1 Pfizer Corporate Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Medicine for Osteoarthritis Pain Major Product Offerings
7.1.4 Pfizer Medicine for Osteoarthritis Pain Sales and Revenue in Global (2016-2021)
7.1.5 Pfizer Key News
7.2 Johnson and Johnson
7.2.1 Johnson and Johnson Corporate Summary
7.2.2 Johnson and Johnson Business Overview
7.2.3 Johnson and Johnson Medicine for Osteoarthritis Pain Major Product Offerings
7.2.4 Johnson and Johnson Medicine for Osteoarthritis Pain Sales and Revenue in Global (2016-2021)
7.2.5 Johnson and Johnson Key News
7.3 GlaxoSmithKline
7.3.1 GlaxoSmithKline Corporate Summary
7.3.2 GlaxoSmithKline Business Overview
7.3.3 GlaxoSmithKline Medicine for Osteoarthritis Pain Major Product Offerings
7.3.4 GlaxoSmithKline Medicine for Osteoarthritis Pain Sales and Revenue in Global (2016-2021)
7.3.5 GlaxoSmithKline Key News
7.4 Bayer
7.4.1 Bayer Corporate Summary
7.4.2 Bayer Business Overview
7.4.3 Bayer Medicine for Osteoarthritis Pain Major Product Offerings
7.4.4 Bayer Medicine for Osteoarthritis Pain Sales and Revenue in Global (2016-2021)
7.4.5 Bayer Key News
7.5 Eli Lilly
7.5.1 Eli Lilly Corporate Summary
7.5.2 Eli Lilly Business Overview
7.5.3 Eli Lilly Medicine for Osteoarthritis Pain Major Product Offerings
7.5.4 Eli Lilly Medicine for Osteoarthritis Pain Sales and Revenue in Global (2016-2021)
7.5.5 Eli Lilly Key News
7.6 Novartis
7.6.1 Novartis Corporate Summary
7.6.2 Novartis Business Overview
7.6.3 Novartis Medicine for Osteoarthritis Pain Major Product Offerings
7.6.4 Novartis Medicine for Osteoarthritis Pain Sales and Revenue in Global (2016-2021)
7.6.5 Novartis Key News
7.7 Sanofi
7.7.1 Sanofi Corporate Summary
7.7.2 Sanofi Business Overview
7.7.3 Sanofi Medicine for Osteoarthritis Pain Major Product Offerings
7.4.4 Sanofi Medicine for Osteoarthritis Pain Sales and Revenue in Global (2016-2021)
7.7.5 Sanofi Key News
7.8 Horizon Pharma
7.8.1 Horizon Pharma Corporate Summary
7.8.2 Horizon Pharma Business Overview
7.8.3 Horizon Pharma Medicine for Osteoarthritis Pain Major Product Offerings
7.8.4 Horizon Pharma Medicine for Osteoarthritis Pain Sales and Revenue in Global (2016-2021)
7.8.5 Horizon Pharma Key News
7.9 Abbott
7.9.1 Abbott Corporate Summary
7.9.2 Abbott Business Overview
7.9.3 Abbott Medicine for Osteoarthritis Pain Major Product Offerings
7.9.4 Abbott Medicine for Osteoarthritis Pain Sales and Revenue in Global (2016-2021)
7.9.5 Abbott Key News
7.10 Mylan
7.10.1 Mylan Corporate Summary
7.10.2 Mylan Business Overview
7.10.3 Mylan Medicine for Osteoarthritis Pain Major Product Offerings
7.10.4 Mylan Medicine for Osteoarthritis Pain Sales and Revenue in Global (2016-2021)
7.10.5 Mylan Key News
7.11 Daiichi Sankyo
7.11.1 Daiichi Sankyo Corporate Summary
7.11.2 Daiichi Sankyo Medicine for Osteoarthritis Pain Business Overview
7.11.3 Daiichi Sankyo Medicine for Osteoarthritis Pain Major Product Offerings
7.11.4 Daiichi Sankyo Medicine for Osteoarthritis Pain Sales and Revenue in Global (2016-2021)
7.11.5 Daiichi Sankyo Key News
7.12 TEVA
7.12.1 TEVA Corporate Summary
7.12.2 TEVA Medicine for Osteoarthritis Pain Business Overview
7.12.3 TEVA Medicine for Osteoarthritis Pain Major Product Offerings
7.12.4 TEVA Medicine for Osteoarthritis Pain Sales and Revenue in Global (2016-2021)
7.12.5 TEVA Key News
7.13 Almatica Pharma
7.13.1 Almatica Pharma Corporate Summary
7.13.2 Almatica Pharma Medicine for Osteoarthritis Pain Business Overview
7.13.3 Almatica Pharma Medicine for Osteoarthritis Pain Major Product Offerings
7.13.4 Almatica Pharma Medicine for Osteoarthritis Pain Sales and Revenue in Global (2016-2021)
7.13.5 Almatica Pharma Key News
7.14 Astellas Pharma
7.14.1 Astellas Pharma Corporate Summary
7.14.2 Astellas Pharma Business Overview
7.14.3 Astellas Pharma Medicine for Osteoarthritis Pain Major Product Offerings
7.14.4 Astellas Pharma Medicine for Osteoarthritis Pain Sales and Revenue in Global (2016-2021)
7.14.5 Astellas Pharma Key News
7.15 Tide Pharmaceutical
7.15.1 Tide Pharmaceutical Corporate Summary
7.15.2 Tide Pharmaceutical Business Overview
7.15.3 Tide Pharmaceutical Medicine for Osteoarthritis Pain Major Product Offerings
7.15.4 Tide Pharmaceutical Medicine for Osteoarthritis Pain Sales and Revenue in Global (2016-2021)
7.15.5 Tide Pharmaceutical Key News
7.16 Iroko Pharmaceuticals
7.16.1 Iroko Pharmaceuticals Corporate Summary
7.16.2 Iroko Pharmaceuticals Business Overview
7.16.3 Iroko Pharmaceuticals Medicine for Osteoarthritis Pain Major Product Offerings
7.16.4 Iroko Pharmaceuticals Medicine for Osteoarthritis Pain Sales and Revenue in Global (2016-2021)
7.16.5 Iroko Pharmaceuticals Key News
7.17 Hengrui Pharmaceutical
7.17.1 Hengrui Pharmaceutical Corporate Summary
7.17.2 Hengrui Pharmaceutical Business Overview
7.17.3 Hengrui Pharmaceutical Medicine for Osteoarthritis Pain Major Product Offerings
7.17.4 Hengrui Pharmaceutical Medicine for Osteoarthritis Pain Sales and Revenue in Global (2016-2021)
7.17.5 Hengrui Pharmaceutical Key News
7.18 Abiogen Pharma
7.18.1 Abiogen Pharma Corporate Summary
7.18.2 Abiogen Pharma Business Overview
7.18.3 Abiogen Pharma Medicine for Osteoarthritis Pain Major Product Offerings
7.18.4 Abiogen Pharma Medicine for Osteoarthritis Pain Sales and Revenue in Global (2016-2021)
7.18.5 Abiogen Pharma Key News
8 Global Medicine for Osteoarthritis Pain Production Capacity, Analysis
8.1 Global Medicine for Osteoarthritis Pain Production Capacity, 2016-2027
8.2 Medicine for Osteoarthritis Pain Production Capacity of Key Manufacturers in Global Market
8.3 Global Medicine for Osteoarthritis Pain Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Medicine for Osteoarthritis Pain Supply Chain Analysis
10.1 Medicine for Osteoarthritis Pain Industry Value Chain
10.2 Medicine for Osteoarthritis Pain Upstream Market
10.3 Medicine for Osteoarthritis Pain Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Medicine for Osteoarthritis Pain Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer


List of Tables
Table 1. Key Players of Medicine for Osteoarthritis Pain in Global Market
Table 2. Top Medicine for Osteoarthritis Pain Players in Global Market, Ranking by Revenue (2019)
Table 3. Global Medicine for Osteoarthritis Pain Revenue by Companies, (US$, Mn), 2016-2021
Table 4. Global Medicine for Osteoarthritis Pain Revenue Share by Companies, 2016-2021
Table 5. Global Medicine for Osteoarthritis Pain Sales by Companies, (K Units), 2016-2021
Table 6. Global Medicine for Osteoarthritis Pain Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Medicine for Osteoarthritis Pain Price (2016-2021) & (USD/Unit)
Table 8. Global Manufacturers Medicine for Osteoarthritis Pain Product Type
Table 9. List of Global Tier 1 Medicine for Osteoarthritis Pain Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Medicine for Osteoarthritis Pain Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - Global Medicine for Osteoarthritis Pain Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Global Medicine for Osteoarthritis Pain Revenue (US$, Mn), 2016-2021
Table 13. By Type - Global Medicine for Osteoarthritis Pain Revenue (US$, Mn), 2022-2027
Table 14. By Type - Global Medicine for Osteoarthritis Pain Sales (K Units), 2016-2021
Table 15. By Type - Global Medicine for Osteoarthritis Pain Sales (K Units), 2022-2027
Table 16. By Application - Global Medicine for Osteoarthritis Pain Revenue, (US$, Mn), 2021 VS 2027
Table 17. By Application - Global Medicine for Osteoarthritis Pain Revenue (US$, Mn), 2016-2021
Table 18. By Application - Global Medicine for Osteoarthritis Pain Revenue (US$, Mn), 2022-2027
Table 19. By Application - Global Medicine for Osteoarthritis Pain Sales (K Units), 2016-2021
Table 20. By Application - Global Medicine for Osteoarthritis Pain Sales (K Units), 2022-2027
Table 21. By Region - Global Medicine for Osteoarthritis Pain Revenue, (US$, Mn), 2021 VS 2027
Table 22. By Region - Global Medicine for Osteoarthritis Pain Revenue (US$, Mn), 2016-2021
Table 23. By Region - Global Medicine for Osteoarthritis Pain Revenue (US$, Mn), 2022-2027
Table 24. By Region - Global Medicine for Osteoarthritis Pain Sales (K Units), 2016-2021
Table 25. By Region - Global Medicine for Osteoarthritis Pain Sales (K Units), 2022-2027
Table 26. By Country - North America Medicine for Osteoarthritis Pain Revenue, (US$, Mn), 2016-2021
Table 27. By Country - North America Medicine for Osteoarthritis Pain Revenue, (US$, Mn), 2022-2027
Table 28. By Country - North America Medicine for Osteoarthritis Pain Sales, (K Units), 2016-2021
Table 29. By Country - North America Medicine for Osteoarthritis Pain Sales, (K Units), 2022-2027
Table 30. By Country - Europe Medicine for Osteoarthritis Pain Revenue, (US$, Mn), 2016-2021
Table 31. By Country - Europe Medicine for Osteoarthritis Pain Revenue, (US$, Mn), 2022-2027
Table 32. By Country - Europe Medicine for Osteoarthritis Pain Sales, (K Units), 2016-2021
Table 33. By Country - Europe Medicine for Osteoarthritis Pain Sales, (K Units), 2022-2027
Table 34. By Region - Asia Medicine for Osteoarthritis Pain Revenue, (US$, Mn), 2016-2021
Table 35. By Region - Asia Medicine for Osteoarthritis Pain Revenue, (US$, Mn), 2022-2027
Table 36. By Region - Asia Medicine for Osteoarthritis Pain Sales, (K Units), 2016-2021
Table 37. By Region - Asia Medicine for Osteoarthritis Pain Sales, (K Units), 2022-2027
Table 38. By Country - South America Medicine for Osteoarthritis Pain Revenue, (US$, Mn), 2016-2021
Table 39. By Country - South America Medicine for Osteoarthritis Pain Revenue, (US$, Mn), 2022-2027
Table 40. By Country - South America Medicine for Osteoarthritis Pain Sales, (K Units), 2016-2021
Table 41. By Country - South America Medicine for Osteoarthritis Pain Sales, (K Units), 2022-2027
Table 42. By Country - Middle East & Africa Medicine for Osteoarthritis Pain Revenue, (US$, Mn), 2016-2021
Table 43. By Country - Middle East & Africa Medicine for Osteoarthritis Pain Revenue, (US$, Mn), 2022-2027
Table 44. By Country - Middle East & Africa Medicine for Osteoarthritis Pain Sales, (K Units), 2016-2021
Table 45. By Country - Middle East & Africa Medicine for Osteoarthritis Pain Sales, (K Units), 2022-2027
Table 46. Pfizer Corporate Summary
Table 47. Pfizer Medicine for Osteoarthritis Pain Product Offerings
Table 48. Pfizer Medicine for Osteoarthritis Pain Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 49. Johnson and Johnson Corporate Summary
Table 50. Johnson and Johnson Medicine for Osteoarthritis Pain Product Offerings
Table 51. Johnson and Johnson Medicine for Osteoarthritis Pain Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 52. GlaxoSmithKline Corporate Summary
Table 53. GlaxoSmithKline Medicine for Osteoarthritis Pain Product Offerings
Table 54. GlaxoSmithKline Medicine for Osteoarthritis Pain Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 55. Bayer Corporate Summary
Table 56. Bayer Medicine for Osteoarthritis Pain Product Offerings
Table 57. Bayer Medicine for Osteoarthritis Pain Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 58. Eli Lilly Corporate Summary
Table 59. Eli Lilly Medicine for Osteoarthritis Pain Product Offerings
Table 60. Eli Lilly Medicine for Osteoarthritis Pain Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 61. Novartis Corporate Summary
Table 62. Novartis Medicine for Osteoarthritis Pain Product Offerings
Table 63. Novartis Medicine for Osteoarthritis Pain Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 64. Sanofi Corporate Summary
Table 65. Sanofi Medicine for Osteoarthritis Pain Product Offerings
Table 66. Sanofi Medicine for Osteoarthritis Pain Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 67. Horizon Pharma Corporate Summary
Table 68. Horizon Pharma Medicine for Osteoarthritis Pain Product Offerings
Table 69. Horizon Pharma Medicine for Osteoarthritis Pain Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 70. Abbott Corporate Summary
Table 71. Abbott Medicine for Osteoarthritis Pain Product Offerings
Table 72. Abbott Medicine for Osteoarthritis Pain Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 73. Mylan Corporate Summary
Table 74. Mylan Medicine for Osteoarthritis Pain Product Offerings
Table 75. Mylan Medicine for Osteoarthritis Pain Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 76. Daiichi Sankyo Corporate Summary
Table 77. Daiichi Sankyo Medicine for Osteoarthritis Pain Product Offerings
Table 78. Daiichi Sankyo Medicine for Osteoarthritis Pain Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 79. TEVA Corporate Summary
Table 80. TEVA Medicine for Osteoarthritis Pain Product Offerings
Table 81. TEVA Medicine for Osteoarthritis Pain Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 82. Almatica Pharma Corporate Summary
Table 83. Almatica Pharma Medicine for Osteoarthritis Pain Product Offerings
Table 84. Almatica Pharma Medicine for Osteoarthritis Pain Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 85. Astellas Pharma Corporate Summary
Table 86. Astellas Pharma Medicine for Osteoarthritis Pain Product Offerings
Table 87. Astellas Pharma Medicine for Osteoarthritis Pain Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 88. Tide Pharmaceutical Corporate Summary
Table 89. Tide Pharmaceutical Medicine for Osteoarthritis Pain Product Offerings
Table 90. Tide Pharmaceutical Medicine for Osteoarthritis Pain Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 91. Iroko Pharmaceuticals Corporate Summary
Table 92. Iroko Pharmaceuticals Medicine for Osteoarthritis Pain Product Offerings
Table 93. Iroko Pharmaceuticals Medicine for Osteoarthritis Pain Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 94. Hengrui Pharmaceutical Corporate Summary
Table 95. Hengrui Pharmaceutical Medicine for Osteoarthritis Pain Product Offerings
Table 96. Hengrui Pharmaceutical Medicine for Osteoarthritis Pain Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 97. Abiogen Pharma Corporate Summary
Table 98. Abiogen Pharma Medicine for Osteoarthritis Pain Product Offerings
Table 99. Abiogen Pharma Medicine for Osteoarthritis Pain Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 100. Medicine for Osteoarthritis Pain Production Capacity (K Units) of Key Manufacturers in Global Market, 2019-2021 (K Units)
Table 101. Global Medicine for Osteoarthritis Pain Capacity Market Share of Key Manufacturers, 2019-2021
Table 102. Global Medicine for Osteoarthritis Pain Production by Region, 2016-2021 (K Units)
Table 103. Global Medicine for Osteoarthritis Pain Production by Region, 2022-2027 (K Units)
Table 104. Medicine for Osteoarthritis Pain Market Opportunities & Trends in Global Market
Table 105. Medicine for Osteoarthritis Pain Market Drivers in Global Market
Table 106. Medicine for Osteoarthritis Pain Market Restraints in Global Market
Table 107. Medicine for Osteoarthritis Pain Raw Materials
Table 108. Medicine for Osteoarthritis Pain Raw Materials Suppliers in Global Market
Table 109. Typical Medicine for Osteoarthritis Pain Downstream
Table 110. Medicine for Osteoarthritis Pain Downstream Clients in Global Market
Table 111. Medicine for Osteoarthritis Pain Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Medicine for Osteoarthritis Pain Segment by Type
Figure 2. Medicine for Osteoarthritis Pain Segment by Application
Figure 3. Global Medicine for Osteoarthritis Pain Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Medicine for Osteoarthritis Pain Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Medicine for Osteoarthritis Pain Revenue, 2016-2027 (US$, Mn)
Figure 7. Medicine for Osteoarthritis Pain Sales in Global Market: 2016-2027 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Medicine for Osteoarthritis Pain Revenue in 2020
Figure 9. By Type - Global Medicine for Osteoarthritis Pain Sales Market Share, 2016-2027
Figure 10. By Type - Global Medicine for Osteoarthritis Pain Revenue Market Share, 2016-2027
Figure 11. By Type - Global Medicine for Osteoarthritis Pain Price (USD/Unit), 2016-2027
Figure 12. By Application - Global Medicine for Osteoarthritis Pain Sales Market Share, 2016-2027
Figure 13. By Application - Global Medicine for Osteoarthritis Pain Revenue Market Share, 2016-2027
Figure 14. By Application - Global Medicine for Osteoarthritis Pain Price (USD/Unit), 2016-2027
Figure 15. By Region - Global Medicine for Osteoarthritis Pain Sales Market Share, 2016-2027
Figure 16. By Region - Global Medicine for Osteoarthritis Pain Revenue Market Share, 2016-2027
Figure 17. By Country - North America Medicine for Osteoarthritis Pain Revenue Market Share, 2016-2027
Figure 18. By Country - North America Medicine for Osteoarthritis Pain Sales Market Share, 2016-2027
Figure 19. US Medicine for Osteoarthritis Pain Revenue, (US$, Mn), 2016-2027
Figure 20. Canada Medicine for Osteoarthritis Pain Revenue, (US$, Mn), 2016-2027
Figure 21. Mexico Medicine for Osteoarthritis Pain Revenue, (US$, Mn), 2016-2027
Figure 22. By Country - Europe Medicine for Osteoarthritis Pain Revenue Market Share, 2016-2027
Figure 23. By Country - Europe Medicine for Osteoarthritis Pain Sales Market Share, 2016-2027
Figure 24. Germany Medicine for Osteoarthritis Pain Revenue, (US$, Mn), 2016-2027
Figure 25. France Medicine for Osteoarthritis Pain Revenue, (US$, Mn), 2016-2027
Figure 26. U.K. Medicine for Osteoarthritis Pain Revenue, (US$, Mn), 2016-2027
Figure 27. Italy Medicine for Osteoarthritis Pain Revenue, (US$, Mn), 2016-2027
Figure 28. Russia Medicine for Osteoarthritis Pain Revenue, (US$, Mn), 2016-2027
Figure 29. Nordic Countries Medicine for Osteoarthritis Pain Revenue, (US$, Mn), 2016-2027
Figure 30. Benelux Medicine for Osteoarthritis Pain Revenue, (US$, Mn), 2016-2027
Figure 31. By Region - Asia Medicine for Osteoarthritis Pain Revenue Market Share, 2016-2027
Figure 32. By Region - Asia Medicine for Osteoarthritis Pain Sales Market Share, 2016-2027
Figure 33. China Medicine for Osteoarthritis Pain Revenue, (US$, Mn), 2016-2027
Figure 34. Japan Medicine for Osteoarthritis Pain Revenue, (US$, Mn), 2016-2027
Figure 35. South Korea Medicine for Osteoarthritis Pain Revenue, (US$, Mn), 2016-2027
Figure 36. Southeast Asia Medicine for Osteoarthritis Pain Revenue, (US$, Mn), 2016-2027
Figure 37. India Medicine for Osteoarthritis Pain Revenue, (US$, Mn), 2016-2027
Figure 38. By Country - South America Medicine for Osteoarthritis Pain Revenue Market Share, 2016-2027
Figure 39. By Country - South America Medicine for Osteoarthritis Pain Sales Market Share, 2016-2027
Figure 40. Brazil Medicine for Osteoarthritis Pain Revenue, (US$, Mn), 2016-2027
Figure 41. Argentina Medicine for Osteoarthritis Pain Revenue, (US$, Mn), 2016-2027
Figure 42. By Country - Middle East & Africa Medicine for Osteoarthritis Pain Revenue Market Share, 2016-2027
Figure 43. By Country - Middle East & Africa Medicine for Osteoarthritis Pain Sales Market Share, 2016-2027
Figure 44. Turkey Medicine for Osteoarthritis Pain Revenue, (US$, Mn), 2016-2027
Figure 45. Israel Medicine for Osteoarthritis Pain Revenue, (US$, Mn), 2016-2027
Figure 46. Saudi Arabia Medicine for Osteoarthritis Pain Revenue, (US$, Mn), 2016-2027
Figure 47. UAE Medicine for Osteoarthritis Pain Revenue, (US$, Mn), 2016-2027
Figure 48. Global Medicine for Osteoarthritis Pain Production Capacity (K Units), 2016-2027
Figure 49. The Percentage of Production Medicine for Osteoarthritis Pain by Region, 2020 VS 2027
Figure 50. Medicine for Osteoarthritis Pain Industry Value Chain
Figure 51. Marketing Channels

Pfizer
Johnson and Johnson
GlaxoSmithKline
Bayer
Eli Lilly
Novartis
Sanofi
Horizon Pharma
Abbott
Mylan
Daiichi Sankyo
TEVA
Almatica Pharma
Astellas Pharma
Tide Pharmaceutical
Iroko Pharmaceuticals
Hengrui Pharmaceutical
Abiogen Pharma